EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

VEXAS Syndrome and Alzheimer’s Disease—Are There Connections?

Aleksandra Sowa iD, Marta Malicka iD, Magdalena Biernacka iD, Jan Aleksander Beszłej, Jerzy Leszek

Brain Sciences · 26.05.2025 · 15 (6) · 573

DOI: 10.3390/brainsci15060573 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Brain Sciences, online erschienen am 26.05.2025. Verfasst von Aleksandra Sowa und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Wroclaw Medical University, 50-367 Wroclaw, Poland. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

VEXAS syndrome and Alzheimer’s disease (AD), though distinct in clinical manifestations, share overlapping pathophysiological mechanisms, including systemic inflammation, protein misfolding, and vascular dysfunction. VEXAS syndrome, a rare autoinflammatory disorder characterized by somatic UBA1 mutations, systemic inflammation, and hematologic abnormalities, presents primarily in older males. Meanwhile, AD, the leading cause of dementia, involves progressive neurodegeneration driven by amyloid-beta plaques, tau tangles, and chronic neuroinflammation. This article explores potential connections between the two conditions, focusing on inflammation, neurovascular changes and cellular stress. Systemic inflammation observed in VEXAS syndrome may potentiate neuroinflammatory processes in Alzheimer’s disease (AD), as circulating proinflammatory cytokines have the capacity to cross the blood–brain barrier (BBB), thereby inducing glial activation and promoting neuroinflammation. Additionally, coexisting vascular dysfunctions characteristic of both conditions may synergistically contribute to accelerated cognitive decline. Both conditions involve disruption of the ubiquitin–proteasome system, with UBA1 mutations being specific to VEXAS. Given the established role of UBA1 in maintaining neuronal homeostasis, investigating the overlapping and distinct molecular mechanisms may provide valuable insights into their pathophysiology. The review underscores the need for further research to elucidate these links and improve therapeutic strategies, especially for individuals affected by both disorders.

Schlagwörter

Stichwörter der Autor:innen

Alzheimer’s diseaseUBA1VEXAScognitive declinedementiainflammationneurodegeneration

Autor:innen und Institutionen

  • Department of Psychiatry, Wroclaw Medical University, 50-367 Wroclaw, Poland.

ORCID-Profile: Aleksandra Sowa, Marta Malicka, Magdalena Biernacka

Zitieren

APA

Sowa, A., Malicka, M., Biernacka, M., Beszłej, J. A., & Leszek, J. (2025). VEXAS Syndrome and Alzheimer’s Disease—Are There Connections?. Brain Sciences, 15(6), 573. https://doi.org/10.3390/brainsci15060573

Vancouver

Sowa A, Malicka M, Biernacka M, Beszłej JA, Leszek J. VEXAS Syndrome and Alzheimer’s Disease—Are There Connections?. Brain Sciences. 2025;15(6):573. doi:10.3390/brainsci15060573

BibTeX
@article{Sowa2025,
  author = {Sowa, Aleksandra and Malicka, Marta and Biernacka, Magdalena and Beszłej, Jan Aleksander and Leszek, Jerzy},
  title = {VEXAS Syndrome and Alzheimer’s Disease—Are There Connections?},
  journal = {Brain Sciences},
  year = {2025},
  volume = {15},
  number = {6},
  pages = {573},
  doi = {10.3390/brainsci15060573}
}
Kostenlos starten →